Trocoxil is a long acting Non-Steroidal Anti-Inflammatory indicated for dogs with Degenerative Joint Disease. This revolutionary medication represents the veterinary practitioner’s best chance to implement a ‘best practice’ approach in continuously relieving the pain and suffering of chronic osteoarthritis in dogs without compromising patient safety. Trocoxil has been available in Australia for a number of years. This presentation will address the compelling reasons for Trocoxil usage, give insight to the Australian experience of the product’s safety, and allow ample opportunity for questions.
This webinar is organised in co-operation with Vetlink Media Solutions and sponsored by Zoetis.
Recording from 29.05.2018
Speaker:
Richard L’Estrange
BVSc (hons), MANZCVS (Vet Pharmacology)